New Insights on Potential Permanent Pacemaker Predictors in TAVR Using the Largest Self-expandable Device
Overview
Authors
Affiliations
Background: Post-procedural conduction disorders following transcatheter aortic valve replacement (TAVR) still remain frequent, especially using the largest self-expandable device (Medtronic Corevalve Evolut R, 34 mm, STHV-34). We, therefore, assessed previously described, predictive factors of permanent pacemaker (PPM) implantation in the context of the STHV-34, including calcification distribution, implantation depth and membranous septum length (MSL).
Methods: We performed a dual centre analysis of 130 of 182 consecutive patients treated with STHV-34, further stratified into subjects without post-procedural PPM (-PPM n=100, 76.9%) and those requiring post-procedural PPM (+PPM n=30, 23.1%). These events were further analyzed by univariate and multivariate analysis according to several underlying conditions.
Results: Multivariate analysis only depicted previous right bundle branch block [RBBB; OR: 11.52 (2.63-50.44), P=0.001] and eccentricity index of the left ventricular outflow tract (LVOT-EI) >0.3 [OR: 3.07 (1.22-7.77), P=0.018] as highly predictive for PPM-need, being also confirmed by c-statistics [area under the curve (AUC) =0.68; 95% confidence interval (CI): 0.57-0.80; P=0.0025]. There was only moderate correlation of implantation depth over the MSL in terms of PPM prediction (r=0.23; P<0.0001).
Conclusions: This study offers new insights into potential PPM predictors using the STHV-34: previous RBBB and a pronounced LVOT-EI were independent predictors of PPM, while most of the previously reported determinants failed to predict PPM-need including MSL and implantation depth.
Factors Influencing Implantation Depth During Transcatheter Aortic Valve Replacement.
Veulemans V, Maier O, Zeus T Interv Cardiol. 2024; 19:e01.
PMID: 38464494 PMC: 10918527. DOI: 10.15420/icr.2023.05.
Lauten P, Costello-Boerrigter L, Goebel B, Gonzalez-Lopez D, Schreiber M, Kuntze T J Cardiovasc Dev Dis. 2023; 10(6).
PMID: 37367395 PMC: 10299451. DOI: 10.3390/jcdd10060230.
Veulemans V, Wilde N, Wienemann H, Adrichem R, Hokken T, Al-Kassou B Front Cardiovasc Med. 2023; 9:1064916.
PMID: 36684595 PMC: 9849574. DOI: 10.3389/fcvm.2022.1064916.
Factors associated with a high or low implantation of self-expanding devices in TAVR.
Veulemans V, Maier O, Piayda K, Berning K, Binnebossel S, Polzin A Clin Res Cardiol. 2021; 110(12):1930-1938.
PMID: 34165599 PMC: 8639548. DOI: 10.1007/s00392-021-01901-3.